Peptide Synthesis Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The peptide synthesis market size has grown strongly in recent years. It will grow from $5.69 billion in 2024 to $6.19 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization.

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rapid growth in therapeutic peptides, increasing demand for customized peptides, growing role in drug discovery and development, focus on peptide libraries for screening. Major trends in the forecast period include development of peptide mimetics, adoption of novel amino acid derivatives, peptide cyclization techniques, innovations in solid-phase peptide synthesis (SPPs), utilization of click chemistry.

The rising prevalence of chronic diseases is expected to drive the growth of the peptide synthesis market moving forward. Chronic diseases are long-term health conditions or non-communicable diseases (NCDs) that persist over extended periods and often develop gradually. Peptide synthesis plays a key role in addressing chronic diseases, as certain peptides possess anti-inflammatory and antioxidant properties that may help prevent conditions such as cardiovascular diseases. By targeting specific cellular processes and signaling pathways, peptides offer new therapeutic and management options for chronic diseases. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, the age-standardized death rate due to chronic conditions was 490 per 100,000 people, an increase from 459 per 100,000 in 2021. As a result, the growing incidence of chronic diseases is driving the expansion of the peptide synthesis market.

The growth in healthcare expenditure is anticipated to accelerate the development of the peptide synthesis market. Healthcare expenditure is a broad measure that encompasses the financial resources allocated to healthcare services, medical treatments, public health programs, and the overall healthcare system. The high costs associated with peptide molecules in the pharmaceutical and nutrition sectors are attributed to their therapeutic potential, specificity, and low toxicity. For instance, in December 2023, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, U.S. healthcare spending increased by 4.1% in 2022, totaling $4.5 trillion, surpassing the 3.2% increase seen in 2021. Therefore, the rise in healthcare expenditure is propelling the growth of the peptide synthesis market.

Major companies in the peptide synthesis market are strategically focusing on introducing advanced peptide synthesizers to gain a competitive edge. Notably, Gyros Protein Technologies launched the PurePep Sonata+ peptide synthesizer in March 2022, offering enhanced efficiency, speed, and accuracy compared to traditional synthesizers. This innovative technology incorporates real-time flow monitoring, ensuring precise and accurate fluid transfers across a diverse range of viscosities.

In May 2023, Biosynth International, Inc., a Swiss-based chemical manufacturing company, acquired Cambridge Research Biochemicals to strengthen its peptide division. This acquisition brings CRB's expertise in intricate peptide chemistry and fluorescent dye labeling, enhancing Biosynth's capabilities in the peptide synthesis market.

Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix.

North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peptide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Peptide synthesis is the laboratory process of producing peptides, which are short chains of amino acids linked together by chemical bonds. These synthesized peptides find various applications in research, drug development, and medical diagnostics, particularly for generating precise sequences that mimic epitopes within specific protein domains.

The primary types of products and services involved in peptide synthesis include reagents, equipment, and services. Reagents in peptide synthesis are chemical compounds or substances used in the creation of peptides. Various technologies are employed in this process, including solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid and recombinant technology. These products and services are utilized by several end-users, including pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs) and contract research organizations (CROs), as well as academic and research institutes.

The peptide synthesis market research report is one of a series of new reports that provides peptide synthesis market statistics, including peptide synthesis industry global market size, regional shares, competitors with a peptide synthesis market share, detailed peptide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. This peptide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.